Drug trial led by Cincinnati researchers gains national media attention

Dr. Evan Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati, is leading clinical trials for a new drug candidate (REGN727) that may do a better job of lowering cholesterol than statins, and with fewer side effects. The New York Times and ABC News took notice last month.

Dr. Evan Stein

Study results were published in a recent issue of The New England Journal of Medicine.

“About 5 to 10 percent of people can’t tolerate statins at all, and more can’t tolerate higher doses,” said Dr. Evan A. Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati and lead author of the drug trials. “It’s still early in development, but for them this is potentially a most promising alternative.”

Recent Posts

Blog Post Archive

Blog Post Categories

Newsticker

Great Lakes NeuroTechnologies awarded $1.5M NIH funding to expand Parkinson’s telemedicine to mobile aps | Great Lakes NeuroTechnologies, April 15, 2014

Cardinal Health announces an annual $600K OSU College of Pharmacy Scholarship | Ohio State University, April 14, 2014

State legislation, funding would create pilot program to help students in STEM fields | The News-Herald, April 14, 2014

Nationwide Children’s Hospital: Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in children | Nationwide Children's Hospital, April 14, 2014

Akebia Therapeutics’ stock soars this Monday with optimistic analysts’ reports | Cincinnati Business Courier, April 14, 2014

Dayton Children’s pediatric neurology team nationally designated as a Level 3 Epilepsy Center | PR Web, April 14, 2014

Cedarville University School of Pharmacy partnering with regional hospitals | Xenia Gazette, April 14, 2014

Cleveland biomedical industry spotlight, featuring Simbionix | Cleveland.com, April 13, 2014

2014 Innovation Award presented to Assurex Health | Cincinnati Business Courier, April 12, 2014

Freshwater Cleveland interviews Dr. Stanton Gerson of Case Comprehensive Cancer Center, National Center for Regenerative Medicine, and Seidman Cancer Hospital at University Hospitals CMC | Freshwater Cleveland, April 10, 2014

AmerisourceBergen CEO, Governor Kasich kick off construction of the company’s new pharmaceutical distribution center in Columbus | Columbus CEO, April 9, 2014

Sinclair Community College recognized for Exemplary Board/CEO by the American Association of Community Colleges | Digital Journal, April 9, 2014

CWRU grad wins $100,000 in national business competition for malaria diagnosis device | Cleveland.com, April 9, 2014

Medical Mutual of Ohio awards $750k grant to NorTech to support regional growth | Crain's Cleveland Business, April 8, 2014

An interview with Gina Drosos, Assurex Health’s new President | Cincinnati Business Courier, April 8, 2014

Cardinal Health’s AccessClosure deal may herald series of acquisitions | Columbus Business First, April 8, 2014

Regionwide bioscience job fair on Thursday | Dayton Daily News, April 8, 2014

Aerpio Therapeutics to present at Needham Healthcare Conference | Business Wire, April 8, 2014

Alkermes announces positive topline results from pivotal Phase 3 study of Aripiprazole Lauroxil for treatment of Schizophrenia | Business Wire, April 8, 2014

Taylor Strategy Partners’ K.C. McAllister named 2014 Luminary by the Healthcare Businesswomen’s Association | PR Newswire, April 8, 2014